Clinical Research

Avazzia is committed to the ongoing support of evidence-based research to improve patient outcomes. Our electrical stimulation (e-stim) technology is actively used in clinical research studies within renown academic centers and hospitals across the globe. Clinicians and researchers, representing numerous specialties, routinely publish outcomes data in peer-reviewed journals and present their findings at medical conferences.

Data presented has not been reviewed or evaluated by the U.S. FDA. Devices are not intended for the diagnosis or treatment of disease condition. Avazzia devices are U.S. FDA cleared as TENS for symptomatic relief and management of chronic, intractable pain, and adjunctive treatment in the management of post-surgical and post-traumatic pain.

Contraindications and warnings include: pacemakers, implanted electronic equipment. Click here for safety information.

Clinical Research on Avazzia

For details or copies of this research, please contact us.

Completed Clinical Studies

Published Peer Reviewed Studies

Completed Dissertation-level Trials

Published Peer-reviewed Articles

  • David A. Moss, Shannon Goossen, Peter F. Demitry, Matthew J. Snyder, Paul F. Crawford | Science Direct. 2024
  • Myeounggon Lee, Alejandro Zulbaran-Rojas, Miguel Bargas-Ochoa, Bernardo Martinez-Leal, Rasha Bara, Areli Flores-Camargo, M. G. Finco, Ram kinker Mishra, Jaewon Beom, Dipaben Modi, Fidaa Shaib, Bijan Najafi | Scientific Reports. 2024
  • Ram kinker Mishra, Bijan Najafi, Abdullah Hamad, Rasha Bara, Myeounggon Lee, Rania Ibrahim, Mincy Mathew, Talal Talal, Fadwa Al-Ali | Journal of Nephrology, 36. 2023
  • Alejandro Zulbaran-Rojas, Myeounggon Lee, Rasha O. Bara, Areli Flores-Camargo, Gil Spitz, M. G. Finco, Amir Behzad Bagheri, Dipaben Modi, Fidaa Shaib, Bijan Najafi | Physiological Reports. 2023
  • Harikrishna KR Nair, H., Aravinthan Balakrishnan | Wounds Asia Vol 6, Issue 1. 2023.
  • Alejandro Zulbaran-Rojas, A., Ramkinker Mishra, Naima Rodriguez, Rasha O Bara, Myeounggon Lee, Amir Behzad Bagheri, James P Herlihy, Muhammad Siddique, Bijan Najafi | Frontiers in Medicine. 2022.
  • Alejandro Zulbaran-Rojas, A., Catherine Park, Nesreen El-Refaei, Brian Lepow, Bijan Najafi | Journal of Diabetes Science and Technology. 2021.
  • Alejandro Zulbaran-Rojas, A., Catherine Park, Brian Lepow, Bijan Najafi | Journal of the American Podiatric Medical Association. 2021.
  • Marzida Mansor, Zhi Shan Lee, Loh-Pui San, Mee Mei Ng, Nazeh Al-Abd, Mustafa Kassim | Turk J Phys Med Rehab 2021; 67(1):62-68.
  • Harikrishna KR Nair, Sylvia SY Chong | Wounds Asia Vol 3, Issue 3. 2020.
  • Kimberly S Peacock, Erika Stoerke, Salvatore Libretto, Weimin Zhang, Alice Inman, Michael Schlicher, John D Cowsar Jr, David Eddie, Joan Walter | Military Medical Research. 2019.
  • Harikrishna K R Nair | Journal of Wound Care. 2018.
  • Purnima Singh | International Journal of Medical and Exercise Science | Vol 4 (3). 2018.
  • Salian, S. D.Y. Patil | University International Research Journal of Natural and Applied Sciences. 2017.
  • Malcolm R Ing, Philip D Hellreich, Douglas W Johnson, John J Chen | International Journal of Dermatology. 2015.

Dissertation-level Clinical Research

  • Satya Naraparddi, Jay Belmarez, Richard T Dombroski | University of North Texas Health Science Center. 2017.
  • Prakash, S.D.Y. | Patil University. 2015.
  • Ng Mee Mei | University of Malaya. 2014.
  • Lee Zhi Shan | University of Malaya. 2014.
  • Ting, K., Wahab, A., Kumaran, R., Mansor, M.| University of Malaya Medical Center. 2013.

    FDA 510(k) Clearances
    Avazzia Prescription pain relief devices are FDA-cleared for the symptomatic relief and management of chronic, intractable pain, and adjunctive treatment in the management of post-surgical and post-traumatic pain.

    FDA Disclosure
    The intent of the complete bibliography is to respond to requests for information about clinical research on Avazzia medical devices. The statements made in the research studies regarding Avazzia products have not been evaluated by the Food and Drug Administration. These studies may present research and clinical data evaluation that exceed FDA-cleared claims. This dissemination of scientific information is consistent with the FDA’s appreciation of exchanges of medical and scientific information stated in the “Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices, Guidance for Industry,” issued January 2009. This is not intended as promotional materials. These products are not intended to diagnose, treat, cure or prevent any disease. Information presented here is not meant as a substitute for or alternative to information from healthcare practitioners. Full product information is available from Avazzia, Inc., Avazzia.com.

    Request Research
    Skip to content